Squarepoint Ops LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2023$468,672
-2.0%
814,799
+19.7%
0.00%
-50.0%
Q1 2023$478,333
+357.4%
680,514
+1370.6%
0.00%
Q4 2022$104,584
-75.4%
46,276
-65.1%
0.00%
-100.0%
Q3 2022$425,000
-45.3%
132,713
-8.0%
0.00%
-33.3%
Q1 2022$777,000
-64.2%
144,226
-10.2%
0.00%
-50.0%
Q4 2021$2,170,000
+918.8%
160,629
+1252.7%
0.01%
+500.0%
Q3 2021$213,000
-86.0%
11,875
-86.6%
0.00%
-83.3%
Q2 2021$1,519,000
+285.5%
88,501
+349.4%
0.01%
+200.0%
Q1 2021$394,000
-27.6%
19,695
-38.5%
0.00%
-50.0%
Q4 2020$544,000
-45.1%
32,010
-46.4%
0.00%
-69.2%
Q3 2020$990,000
-28.3%
59,700
-22.8%
0.01%
-62.9%
Q1 2020$1,380,000
-47.7%
77,334
-36.8%
0.04%
+118.8%
Q4 2019$2,639,000
-32.4%
122,283
-42.9%
0.02%
-54.3%
Q3 2019$3,903,000
-20.0%
214,299
+44.3%
0.04%
-38.6%
Q4 2018$4,880,000
-65.8%
148,478
-36.6%
0.06%
-66.7%
Q3 2018$14,281,000
+407.3%
234,267
+306.4%
0.17%
+362.2%
Q2 2018$2,815,000
+946.5%
57,648
+319.4%
0.04%
+640.0%
Q2 2017$269,000
-29.0%
13,745
-37.6%
0.01%
-80.0%
Q3 2016$379,000
+101.6%
22,032
+66.9%
0.02%
+108.3%
Q2 2016$188,000
-77.5%
13,198
-78.2%
0.01%
-81.5%
Q1 2016$834,00060,6650.06%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2020
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders